GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Orthofix Medical Inc (NAS:OFIX) » Definitions » Cyclically Adjusted Revenue per Share

Orthofix Medical (Orthofix Medical) Cyclically Adjusted Revenue per Share : $26.96 (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Orthofix Medical Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Orthofix Medical's adjusted revenue per share for the three months ended in Mar. 2024 was $4.997. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $26.96 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Orthofix Medical's average Cyclically Adjusted Revenue Growth Rate was 0.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 1.00% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Orthofix Medical was 16.20% per year. The lowest was -2.60% per year. And the median was 5.10% per year.

As of today (2024-05-31), Orthofix Medical's current stock price is $13.73. Orthofix Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $26.96. Orthofix Medical's Cyclically Adjusted PS Ratio of today is 0.51.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Orthofix Medical was 2.53. The lowest was 0.37. And the median was 1.36.


Orthofix Medical Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Orthofix Medical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthofix Medical Cyclically Adjusted Revenue per Share Chart

Orthofix Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.15 24.50 25.53 26.55 26.70

Orthofix Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.82 26.96 27.02 26.70 26.96

Competitive Comparison of Orthofix Medical's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Orthofix Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orthofix Medical's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Orthofix Medical's Cyclically Adjusted PS Ratio falls into.



Orthofix Medical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Orthofix Medical's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.997/131.7762*131.7762
=4.997

Current CPI (Mar. 2024) = 131.7762.

Orthofix Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 5.423 100.560 7.106
201409 5.380 100.428 7.059
201412 5.388 99.070 7.167
201503 4.792 99.621 6.339
201506 5.316 100.684 6.958
201509 5.364 100.392 7.041
201512 5.558 99.792 7.339
201603 5.260 100.470 6.899
201606 5.735 101.688 7.432
201609 5.358 101.861 6.932
201612 5.982 101.863 7.739
201703 5.714 102.862 7.320
201706 5.939 103.349 7.573
201709 5.667 104.136 7.171
201712 6.214 104.011 7.873
201803 5.759 105.290 7.208
201806 5.922 106.317 7.340
201809 6.018 106.507 7.446
201812 6.354 105.998 7.899
201903 5.686 107.251 6.986
201906 6.151 108.070 7.500
201909 5.987 108.329 7.283
201912 6.371 108.420 7.743
202003 5.431 108.902 6.572
202006 3.806 108.767 4.611
202009 5.721 109.815 6.865
202012 5.998 109.897 7.192
202103 5.408 111.754 6.377
202106 6.089 114.631 7.000
202109 5.687 115.734 6.475
202112 6.297 117.630 7.054
202203 5.348 121.301 5.810
202206 5.870 125.017 6.187
202209 5.674 125.227 5.971
202212 6.053 125.222 6.370
202303 4.903 127.348 5.073
202306 5.087 128.729 5.207
202309 4.940 129.860 5.013
202312 5.394 129.419 5.492
202403 4.997 131.776 4.997

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Orthofix Medical  (NAS:OFIX) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Orthofix Medical's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=13.73/26.96
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Orthofix Medical was 2.53. The lowest was 0.37. And the median was 1.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Orthofix Medical Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Orthofix Medical's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Orthofix Medical (Orthofix Medical) Business Description

Traded in Other Exchanges
Address
3451 Plano Parkway, Lewisville, TX, USA, 75056
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Executives
James F. Hinrichs director 3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Puja Leekha officer: CECO & Interim CLO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Geoffrey C Gillespie officer: VP, Controller, Interim CFO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kevin J. Kenny officer: President of Global Spine C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Shweta Maniar director C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
John J. Bostjancic officer: CFO C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081
Keith Valentine director, officer: President & CEO 7475 LUSK BLVD., SAN DIEGO CA 92121
Henneman John B Iii director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Patrick L Keran officer: Chief Legal Officer 6725 MESA RIDGE RD., SUITE 100, SAN DIEGO CA 92121
Thomas A. West director C/O INTERSECT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Michael E Paolucci director 7475 LUSK BLVD., SAN DIEGO CA 92121
Catherine M Burzik director
Rice Doug officer: CFO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kimberley A. Elting officer: Chief Legal Officer 3451 PLANO PARKWAY, LEWISVILLE TX 75056

Orthofix Medical (Orthofix Medical) Headlines

From GuruFocus